Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Cannabis-based Medicines Revenue

1.5 Market Analysis by Type

1.5.1 Global Cannabis-based Medicines Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 CBD (Cannabidiol) Based

1.5.3 THC (Tetrahydrocannabinol) Based

1.5.4 Others

1.6 Market by Application

1.6.1 Global Cannabis-based Medicines Market Share by Application: 2022-2027

1.6.2 Oral Solution

1.6.3 Tablets

1.6.4 Patches

1.6.5 Others

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Cannabis-based Medicines Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Cannabis-based Medicines Market Players Profiles

3.1 GW Pharmaceuticals plc

3.1.1 GW Pharmaceuticals plc Company Profile

3.1.2 GW Pharmaceuticals plc Cannabis-based Medicines Product Specification

3.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 INSYS Therapeutics

3.2.1 INSYS Therapeutics Company Profile

3.2.2 INSYS Therapeutics Cannabis-based Medicines Product Specification

3.2.3 INSYS Therapeutics Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Aequus Pharmaceuticals

3.3.1 Aequus Pharmaceuticals Company Profile

3.3.2 Aequus Pharmaceuticals Cannabis-based Medicines Product Specification

3.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Axim Biotechnologies

3.4.1 Axim Biotechnologies Company Profile

3.4.2 Axim Biotechnologies Cannabis-based Medicines Product Specification

3.4.3 Axim Biotechnologies Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Revive Therapeutics

3.5.1 Revive Therapeutics Company Profile

3.5.2 Revive Therapeutics Cannabis-based Medicines Product Specification

3.5.3 Revive Therapeutics Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 MGC Pharmaceuticals

3.6.1 MGC Pharmaceuticals Company Profile

3.6.2 MGC Pharmaceuticals Cannabis-based Medicines Product Specification

3.6.3 MGC Pharmaceuticals Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 ECHO Pharmaceuticals

3.7.1 ECHO Pharmaceuticals Company Profile

3.7.2 ECHO Pharmaceuticals Cannabis-based Medicines Product Specification

3.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Cannabis-based Medicines Market Competition by Market Players

4.1 Global Cannabis-based Medicines Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Cannabis-based Medicines Revenue Market Share by Market Players (2016-2021)

4.3 Global Cannabis-based Medicines Average Price by Market Players (2016-2021)

5 Global Cannabis-based Medicines Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Cannabis-based Medicines Market Size (2016-2021)

5.1.2 Cannabis-based Medicines Key Players in North America (2016-2021)

5.1.3 North America Cannabis-based Medicines Market Size by Type (2016-2021)

5.1.4 North America Cannabis-based Medicines Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Cannabis-based Medicines Market Size (2016-2021)

5.2.2 Cannabis-based Medicines Key Players in East Asia (2016-2021)

5.2.3 East Asia Cannabis-based Medicines Market Size by Type (2016-2021)

5.2.4 East Asia Cannabis-based Medicines Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Cannabis-based Medicines Market Size (2016-2021)

5.3.2 Cannabis-based Medicines Key Players in Europe (2016-2021)

5.3.3 Europe Cannabis-based Medicines Market Size by Type (2016-2021)

5.3.4 Europe Cannabis-based Medicines Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Cannabis-based Medicines Market Size (2016-2021)

5.4.2 Cannabis-based Medicines Key Players in South Asia (2016-2021)

5.4.3 South Asia Cannabis-based Medicines Market Size by Type (2016-2021)

5.4.4 South Asia Cannabis-based Medicines Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Cannabis-based Medicines Market Size (2016-2021)

5.5.2 Cannabis-based Medicines Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Cannabis-based Medicines Market Size by Type (2016-2021)

5.5.4 Southeast Asia Cannabis-based Medicines Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Cannabis-based Medicines Market Size (2016-2021)

5.6.2 Cannabis-based Medicines Key Players in Middle East (2016-2021)

5.6.3 Middle East Cannabis-based Medicines Market Size by Type (2016-2021)

5.6.4 Middle East Cannabis-based Medicines Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Cannabis-based Medicines Market Size (2016-2021)

5.7.2 Cannabis-based Medicines Key Players in Africa (2016-2021)

5.7.3 Africa Cannabis-based Medicines Market Size by Type (2016-2021)

5.7.4 Africa Cannabis-based Medicines Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Cannabis-based Medicines Market Size (2016-2021)

5.8.2 Cannabis-based Medicines Key Players in Oceania (2016-2021)

5.8.3 Oceania Cannabis-based Medicines Market Size by Type (2016-2021)

5.8.4 Oceania Cannabis-based Medicines Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Cannabis-based Medicines Market Size (2016-2021)

5.9.2 Cannabis-based Medicines Key Players in South America (2016-2021)

5.9.3 South America Cannabis-based Medicines Market Size by Type (2016-2021)

5.9.4 South America Cannabis-based Medicines Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Cannabis-based Medicines Market Size (2016-2021)

5.10.2 Cannabis-based Medicines Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Cannabis-based Medicines Market Size by Type (2016-2021)

5.10.4 Rest of the World Cannabis-based Medicines Market Size by Application (2016-2021)

6 Global Cannabis-based Medicines Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Cannabis-based Medicines Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Cannabis-based Medicines Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Cannabis-based Medicines Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Cannabis-based Medicines Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Cannabis-based Medicines Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Cannabis-based Medicines Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Cannabis-based Medicines Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Cannabis-based Medicines Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Cannabis-based Medicines Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Cannabis-based Medicines Consumption by Countries

7 Global Cannabis-based Medicines Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Cannabis-based Medicines (2022-2027)

7.2 Global Forecasted Revenue of Cannabis-based Medicines (2022-2027)

7.3 Global Forecasted Price of Cannabis-based Medicines (2022-2027)

7.4 Global Forecasted Production of Cannabis-based Medicines by Region (2022-2027)

7.4.1 North America Cannabis-based Medicines Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Cannabis-based Medicines Production, Revenue Forecast (2022-2027)

7.4.3 Europe Cannabis-based Medicines Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Cannabis-based Medicines Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Cannabis-based Medicines Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Cannabis-based Medicines Production, Revenue Forecast (2022-2027)

7.4.7 Africa Cannabis-based Medicines Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Cannabis-based Medicines Production, Revenue Forecast (2022-2027)

7.4.9 South America Cannabis-based Medicines Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Cannabis-based Medicines Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Cannabis-based Medicines by Application (2022-2027)

8 Global Cannabis-based Medicines Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Cannabis-based Medicines by Country

8.2 East Asia Market Forecasted Consumption of Cannabis-based Medicines by Country

8.3 Europe Market Forecasted Consumption of Cannabis-based Medicines by Countriy

8.4 South Asia Forecasted Consumption of Cannabis-based Medicines by Country

8.5 Southeast Asia Forecasted Consumption of Cannabis-based Medicines by Country

8.6 Middle East Forecasted Consumption of Cannabis-based Medicines by Country

8.7 Africa Forecasted Consumption of Cannabis-based Medicines by Country

8.8 Oceania Forecasted Consumption of Cannabis-based Medicines by Country

8.9 South America Forecasted Consumption of Cannabis-based Medicines by Country

8.10 Rest of the world Forecasted Consumption of Cannabis-based Medicines by Country

9 Global Cannabis-based Medicines Sales by Type (2016-2027)

9.1 Global Cannabis-based Medicines Historic Market Size by Type (2016-2021)

9.2 Global Cannabis-based Medicines Forecasted Market Size by Type (2022-2027)

10 Global Cannabis-based Medicines Consumption by Application (2016-2027)

10.1 Global Cannabis-based Medicines Historic Market Size by Application (2016-2021)

10.2 Global Cannabis-based Medicines Forecasted Market Size by Application (2022-2027)

11 Global Cannabis-based Medicines Manufacturing Cost Analysis

11.1 Cannabis-based Medicines Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Cannabis-based Medicines

12 Global Cannabis-based Medicines Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Cannabis-based Medicines Distributors List

12.3 Cannabis-based Medicines Customers

12.4 Cannabis-based Medicines Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Cannabis-based Medicines Revenue (US$ Million) 2016-2021

Table 6. Global Cannabis-based Medicines Market Size by Type (US$ Million): 2022-2027

Table 7. CBD (Cannabidiol) Based Features

Table 8. THC (Tetrahydrocannabinol) Based Features

Table 9. Others Features

Table 16. Global Cannabis-based Medicines Market Size by Application (US$ Million): 2022-2027

Table 17. Oral Solution Case Studies

Table 18. Tablets Case Studies

Table 19. Patches Case Studies

Table 20. Others Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Cannabis-based Medicines Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Cannabis-based Medicines Market Growth Strategy

Table 46. Cannabis-based Medicines SWOT Analysis

Table 47. GW Pharmaceuticals plc Cannabis-based Medicines Product Specification

Table 48. GW Pharmaceuticals plc Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. INSYS Therapeutics Cannabis-based Medicines Product Specification

Table 50. INSYS Therapeutics Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Aequus Pharmaceuticals Cannabis-based Medicines Product Specification

Table 52. Aequus Pharmaceuticals Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Axim Biotechnologies Cannabis-based Medicines Product Specification

Table 54. Table Axim Biotechnologies Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Revive Therapeutics Cannabis-based Medicines Product Specification

Table 56. Revive Therapeutics Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. MGC Pharmaceuticals Cannabis-based Medicines Product Specification

Table 58. MGC Pharmaceuticals Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. ECHO Pharmaceuticals Cannabis-based Medicines Product Specification

Table 60. ECHO Pharmaceuticals Cannabis-based Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Cannabis-based Medicines Production Capacity by Market Players

Table 148. Global Cannabis-based Medicines Production by Market Players (2016-2021)

Table 149. Global Cannabis-based Medicines Production Market Share by Market Players (2016-2021)

Table 150. Global Cannabis-based Medicines Revenue by Market Players (2016-2021)

Table 151. Global Cannabis-based Medicines Revenue Share by Market Players (2016-2021)

Table 152. Global Market Cannabis-based Medicines Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Cannabis-based Medicines Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Cannabis-based Medicines Market Share (2016-2021)

Table 155. North America Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Cannabis-based Medicines Market Share by Type (2016-2021)

Table 157. North America Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Cannabis-based Medicines Market Share by Application (2016-2021)

Table 159. East Asia Cannabis-based Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Cannabis-based Medicines Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Cannabis-based Medicines Market Share (2016-2021)

Table 162. East Asia Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Cannabis-based Medicines Market Share by Type (2016-2021)

Table 164. East Asia Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Cannabis-based Medicines Market Share by Application (2016-2021)

Table 166. Europe Cannabis-based Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Cannabis-based Medicines Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Cannabis-based Medicines Market Share (2016-2021)

Table 169. Europe Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Cannabis-based Medicines Market Share by Type (2016-2021)

Table 171. Europe Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Cannabis-based Medicines Market Share by Application (2016-2021)

Table 173. South Asia Cannabis-based Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Cannabis-based Medicines Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Cannabis-based Medicines Market Share (2016-2021)

Table 176. South Asia Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Cannabis-based Medicines Market Share by Type (2016-2021)

Table 178. South Asia Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Cannabis-based Medicines Market Share by Application (2016-2021)

Table 180. Southeast Asia Cannabis-based Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Cannabis-based Medicines Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Cannabis-based Medicines Market Share (2016-2021)

Table 183. Southeast Asia Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Cannabis-based Medicines Market Share by Type (2016-2021)

Table 185. Southeast Asia Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Cannabis-based Medicines Market Share by Application (2016-2021)

Table 187. Middle East Cannabis-based Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Cannabis-based Medicines Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Cannabis-based Medicines Market Share (2016-2021)

Table 190. Middle East Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Cannabis-based Medicines Market Share by Type (2016-2021)

Table 192. Middle East Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Cannabis-based Medicines Market Share by Application (2016-2021)

Table 194. Africa Cannabis-based Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Cannabis-based Medicines Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Cannabis-based Medicines Market Share (2016-2021)

Table 197. Africa Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Cannabis-based Medicines Market Share by Type (2016-2021)

Table 199. Africa Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Cannabis-based Medicines Market Share by Application (2016-2021)

Table 201. Oceania Cannabis-based Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Cannabis-based Medicines Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Cannabis-based Medicines Market Share (2016-2021)

Table 204. Oceania Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Cannabis-based Medicines Market Share by Type (2016-2021)

Table 206. Oceania Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Cannabis-based Medicines Market Share by Application (2016-2021)

Table 208. South America Cannabis-based Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Cannabis-based Medicines Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Cannabis-based Medicines Market Share (2016-2021)

Table 211. South America Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Cannabis-based Medicines Market Share by Type (2016-2021)

Table 213. South America Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Cannabis-based Medicines Market Share by Application (2016-2021)

Table 215. Rest of the World Cannabis-based Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Cannabis-based Medicines Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Cannabis-based Medicines Market Share (2016-2021)

Table 218. Rest of the World Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Cannabis-based Medicines Market Share by Type (2016-2021)

Table 220. Rest of the World Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Cannabis-based Medicines Market Share by Application (2016-2021)

Table 222. North America Cannabis-based Medicines Consumption by Countries (2016-2021)

Table 223. East Asia Cannabis-based Medicines Consumption by Countries (2016-2021)

Table 224. Europe Cannabis-based Medicines Consumption by Region (2016-2021)

Table 225. South Asia Cannabis-based Medicines Consumption by Countries (2016-2021)

Table 226. Southeast Asia Cannabis-based Medicines Consumption by Countries (2016-2021)

Table 227. Middle East Cannabis-based Medicines Consumption by Countries (2016-2021)

Table 228. Africa Cannabis-based Medicines Consumption by Countries (2016-2021)

Table 229. Oceania Cannabis-based Medicines Consumption by Countries (2016-2021)

Table 230. South America Cannabis-based Medicines Consumption by Countries (2016-2021)

Table 231. Rest of the World Cannabis-based Medicines Consumption by Countries (2016-2021)

Table 232. Global Cannabis-based Medicines Production Forecast by Region (2022-2027)

Table 233. Global Cannabis-based Medicines Sales Volume Forecast by Type (2022-2027)

Table 234. Global Cannabis-based Medicines Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Cannabis-based Medicines Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Cannabis-based Medicines Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Cannabis-based Medicines Sales Price Forecast by Type (2022-2027)

Table 238. Global Cannabis-based Medicines Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Cannabis-based Medicines Consumption Value Forecast by Application (2022-2027)

Table 240. North America Cannabis-based Medicines Consumption Forecast 2022-2027 by Country

Table 241. East Asia Cannabis-based Medicines Consumption Forecast 2022-2027 by Country

Table 242. Europe Cannabis-based Medicines Consumption Forecast 2022-2027 by Country

Table 243. South Asia Cannabis-based Medicines Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Cannabis-based Medicines Consumption Forecast 2022-2027 by Country

Table 245. Middle East Cannabis-based Medicines Consumption Forecast 2022-2027 by Country

Table 246. Africa Cannabis-based Medicines Consumption Forecast 2022-2027 by Country

Table 247. Oceania Cannabis-based Medicines Consumption Forecast 2022-2027 by Country

Table 248. South America Cannabis-based Medicines Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Cannabis-based Medicines Consumption Forecast 2022-2027 by Country

Table 250. Global Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Cannabis-based Medicines Revenue Market Share by Type (2016-2021)

Table 252. Global Cannabis-based Medicines Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Cannabis-based Medicines Revenue Market Share by Type (2022-2027)

Table 254. Global Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Cannabis-based Medicines Revenue Market Share by Application (2016-2021)

Table 256. Global Cannabis-based Medicines Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Cannabis-based Medicines Revenue Market Share by Application (2022-2027)

Table 258. Cannabis-based Medicines Distributors List

Table 259. Cannabis-based Medicines Customers List





Figure 1. Product Figure

Figure 2. Global Cannabis-based Medicines Market Share by Type: 2021 VS 2027

Figure 3. Global Cannabis-based Medicines Market Share by Application: 2021 VS 2027

Figure 4. North America Cannabis-based Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 6. North America Cannabis-based Medicines Consumption Market Share by Countries in 2021

Figure 7. United States Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 8. Canada Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Cannabis-based Medicines Consumption Market Share by Countries in 2021

Figure 12. China Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 13. Japan Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 15. Europe Cannabis-based Medicines Consumption and Growth Rate

Figure 16. Europe Cannabis-based Medicines Consumption Market Share by Region in 2021

Figure 17. Germany Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 19. France Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 20. Italy Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 21. Russia Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 22. Spain Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 25. Poland Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Cannabis-based Medicines Consumption and Growth Rate

Figure 27. South Asia Cannabis-based Medicines Consumption Market Share by Countries in 2021

Figure 28. India Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Cannabis-based Medicines Consumption and Growth Rate

Figure 30. Southeast Asia Cannabis-based Medicines Consumption Market Share by Countries in 2021

Figure 31. Indonesia Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Cannabis-based Medicines Consumption and Growth Rate

Figure 37. Middle East Cannabis-based Medicines Consumption Market Share by Countries in 2021

Figure 38. Turkey Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 40. Iran Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 42. Africa Cannabis-based Medicines Consumption and Growth Rate

Figure 43. Africa Cannabis-based Medicines Consumption Market Share by Countries in 2021

Figure 44. Nigeria Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Cannabis-based Medicines Consumption and Growth Rate

Figure 47. Oceania Cannabis-based Medicines Consumption Market Share by Countries in 2021

Figure 48. Australia Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 49. South America Cannabis-based Medicines Consumption and Growth Rate

Figure 50. South America Cannabis-based Medicines Consumption Market Share by Countries in 2021

Figure 51. Brazil Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Cannabis-based Medicines Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Cannabis-based Medicines Consumption and Growth Rate

Figure 54. Rest of the World Cannabis-based Medicines Consumption Market Share by Countries in 2021

Figure 55. Global Cannabis-based Medicines Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Cannabis-based Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Cannabis-based Medicines Price and Trend Forecast (2022-2027)

Figure 58. North America Cannabis-based Medicines Production Growth Rate Forecast (2022-2027)

Figure 59. North America Cannabis-based Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Cannabis-based Medicines Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Cannabis-based Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Cannabis-based Medicines Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Cannabis-based Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Cannabis-based Medicines Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Cannabis-based Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Cannabis-based Medicines Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Cannabis-based Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Cannabis-based Medicines Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Cannabis-based Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Cannabis-based Medicines Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Cannabis-based Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Cannabis-based Medicines Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Cannabis-based Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Cannabis-based Medicines Production Growth Rate Forecast (2022-2027)

Figure 75. South America Cannabis-based Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Cannabis-based Medicines Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Cannabis-based Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Cannabis-based Medicines Consumption Forecast 2022-2027

Figure 79. East Asia Cannabis-based Medicines Consumption Forecast 2022-2027

Figure 80. Europe Cannabis-based Medicines Consumption Forecast 2022-2027

Figure 81. South Asia Cannabis-based Medicines Consumption Forecast 2022-2027

Figure 82. Southeast Asia Cannabis-based Medicines Consumption Forecast 2022-2027

Figure 83. Middle East Cannabis-based Medicines Consumption Forecast 2022-2027

Figure 84. Africa Cannabis-based Medicines Consumption Forecast 2022-2027

Figure 85. Oceania Cannabis-based Medicines Consumption Forecast 2022-2027

Figure 86. South America Cannabis-based Medicines Consumption Forecast 2022-2027

Figure 87. Rest of the world Cannabis-based Medicines Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Cannabis-based Medicines

Figure 89. Manufacturing Process Analysis of Cannabis-based Medicines

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Cannabis-based Medicines Supply Chain Analysis